Dr. Ali Kasraeian of the renowned Kasraeian Urology in Jacksonville, FL, in partnership with Vituro Health, treated their first patient with Profound Medical’s (NASDAQ:PROF; TSX:PRN) TULSA-PRO medical device for prostate tissue ablation.
“Vituro Health continues to be the frontrunner in ablative technologies,” Clete Walker, CEO of Vituro, said in a statement. “We want to make sure that all of our physicians and patients have access to the newest non-invasive technologies when it comes to the treatment of prostate cancer.”
Dr. Ali Kasraeian completed a fellowship in minimally invasive urological surgery at the world renowned Montsouris Institute in Paris. He specializes in the advanced diagnosis, second opinion consultation and personalized management of prostate cancer as well as minimally invasive surgery for bladder, kidney, and prostate cancers and other urological conditions.
Dr. Kasraeian has been performing HIFU since completing his fellowship in 2008 and trained with TULSA-PRO over the last year, both with Dr. Stephen Scionti.
“I am committed to offering my patients the latest technologies that provide the greatest quality of life results after treatment and the TULSA-PRO with its real-time MRI is our newest tool,” Dr. Kasraeian said.
